Jacobs Levy Equity Management
CINC

Jacobs Levy Equity Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Jacobs Levy Equity Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,335
Closed -$447K – 1101
2022
Q4 		$447K Buy
+36,335
New +$866K ﹤0.01% 809

Jacobs Levy Equity Management's CINC Position: Q1 2023 in Review

Jacobs Levy Equity Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 36,335 shares — an estimated $447K sold.

Jacobs Levy Equity Management first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $447K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Jacobs Levy Equity Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 36,335 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $447K.
  • Jacobs Levy Equity Management first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Jacobs Levy Equity Management's CinCor Pharma, Inc. Common Stock position peaked at $447K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.